“…A countless number of studies unveiling the antidiabetic properties, including early preventive, disease course modifying, and complication limiting effects, of individual nutrients and phytochemicals that are ubiquitously present in BP from different botanical and geographical origins have been published so far. This includes, for example, nutrients including vitamins such as groups B [ 241 , 242 , 243 ], C [ 244 , 245 , 246 ], D [ 247 , 248 , 249 ], and E [ 128 , 250 , 251 ], oligo-elements and other minerals [ 252 , 253 , 254 ], and lipids such as unsaturated fatty acids [ 255 , 256 , 257 ] and phytosterols [ 63 , 258 , 259 ], as well as other phytochemicals including polyphenols such as phenolic acids, flavonoids, and stilbenes (very recent and comprehensive reviews of preclinical and clinical evidence can be found in [ 260 , 261 , 262 , 263 , 264 , 265 , 266 ]). Despite the substantial amount of experimental and clinical evidence of all these BP compounds in the complex pathophysiology of diabetes and in its interaction with other comorbidities, the possible synergistic potential and real clinical outcome of these compounds, which are always combined in BP, have generally been omitted in research and must be further studied by in vivo experiments, and subsequently verified and objectively assessed by clinical studies.…”